{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:31:38Z","timestamp":1787164298151,"version":"build-2736575974"},"reference-count":103,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Pancreatic cancer is a cancer with one of the highest mortality rates and many pancreatic cancer patients present with cachexia at diagnosis. The definition of cancer cachexia is not consistently applied in the clinic or across studies. In general, it is \u201cdefined as a multifactorial syndrome characterised by an ongoing loss of skeletal muscle mass with or without loss of fat mass that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment.\u201d Many regard cancer cachexia as being resistant to dietary interventions. Cachexia is associated with a negative impact on survival and quality of life. In this article, we outline some of the mechanisms of pancreatic cancer cachexia and discuss nutritional interventions to support the management of pancreatic cancer cachexia. Cachexia is driven by a combination of reduced appetite leading to reduced calorie intake, increased metabolism, and systemic inflammation driven by a combination of host cytokines and tumour derived factors. The ketogenic diet showed promising results, but these are yet to be confirmed in human clinical trials over the long-term. L-carnitine supplementation showed improved quality of life and an increase in lean body mass. As a first step towards preventing and managing pancreatic cancer cachexia, nutritional support should be provided through counselling and the provision of oral nutritional supplements to prevent and minimise loss of lean body mass.<\/jats:p>","DOI":"10.3390\/healthcare7030089","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T03:05:26Z","timestamp":1562727926000},"page":"89","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pancreatic Cancer Cachexia: The Role of Nutritional Interventions"],"prefix":"10.3390","volume":"7","author":[{"given":"Toni","family":"Mitchell","sequence":"first","affiliation":[{"name":"School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Clarke","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Goldberg","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-7708","authenticated-orcid":false,"given":"Karen S.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Nutrition, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand"},{"name":"Auckland Cancer Society Research Centre, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bachmann, J., Ketterer, K., Marsch, C., Fechtner, K., Krakowski-Roosen, H., Buchler, M.W., Friess, H., and Martignoni, M.E. (2009). Pancreatic cancer related cachexia: Influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-255"},{"key":"ref_4","unstructured":"The American Cancer Society (2018, December 03). Pancreatic Cancer Risk Factors. Available online: https:\/\/www.cancer.org\/cancer\/pancreatic-cancer\/causes-risks-prevention\/risk-factors.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","unstructured":"Cancer Research UK (2018, December 03). Pancreatic Cancer Survival Statistics. Available online: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/pancreatic-cancer\/survival."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e000097","DOI":"10.1136\/bmjgast-2016-000097","article-title":"Cachexia in cancer: What is in the definition?","volume":"3","author":"Vanhoutte","year":"2016","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_10","first-page":"9361","article-title":"Cachexia and pancreatic cancer: Are there treatment options?","volume":"20","author":"Mueller","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma","volume":"101","author":"Ebrahimi","year":"2004","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.3988","article-title":"A TGF-beta pathway associated with cancer cachexia","volume":"21","author":"Guttridge","year":"2015","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","first-page":"23","article-title":"The Evolving Approach to Management of Cancer Cachexia","volume":"31","author":"Dev","year":"2017","journal-title":"Oncology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphys.2017.00738","article-title":"Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture","volume":"8","author":"Jackman","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjc.6600493","article-title":"Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo","volume":"87","author":"Russell","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12279","DOI":"10.1074\/jbc.272.19.12279","article-title":"Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation","volume":"272","author":"Todorov","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/bjc.1997.433","article-title":"Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients","volume":"76","author":"Cariuk","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/bjc.1997.504","article-title":"Induction of muscle protein degradation by a tumour factor","volume":"76","author":"Lorite","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00520-004-0615-4","article-title":"Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss","volume":"12","author":"Deutsch","year":"2004","journal-title":"Support. Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest Oncol."},{"key":"ref_25","first-page":"1801","article-title":"Energy balance and body composition in cancer patients","volume":"38","author":"Warnold","year":"1978","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1097-0142(19850101)55:1+<290::AID-CNCR2820551314>3.0.CO;2-E","article-title":"Macronutrient requirements in the malnourished cancer patient. How much of what and why?","volume":"55","author":"Dempsey","year":"1985","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_28","first-page":"721s","article-title":"Pathophysiology of cancer cachexia: Current understanding and areas for future research","volume":"42","author":"DeWys","year":"1982","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00520-012-1514-8","article-title":"Symptoms in advanced pancreatic cancer are of importance for energy intake","volume":"21","author":"Bye","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01635589809514717","article-title":"Prognosis of advanced pancreatic cancer patients with reference to calorie intake","volume":"32","author":"Okusaka","year":"1998","journal-title":"Nutr. Cancer"},{"key":"ref_31","unstructured":"Samra, R. (2019, January 11). Chapter 15: Fats and Satiety, Fat Detection: Taste, Texture, and Post Ingestive Effects, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53550\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clnu.2016.12.012","article-title":"Defining the role of dietary intake in determining weight change in patients with cancer cachexia","volume":"37","author":"Nasrah","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clnu.2003.07.001","article-title":"Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer","volume":"23","author":"Davidson","year":"2004","journal-title":"Clin. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.clnu.2005.07.002","article-title":"Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer","volume":"24","author":"Bauer","year":"2005","journal-title":"Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-004-2511-2","article-title":"Parenteral vs. enteral nutrition in the critically ill patient: A meta-analysis of trials using the intention to treat principle","volume":"31","author":"Simpson","year":"2005","journal-title":"Intensive Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clnu.2009.05.010","article-title":"The ESPEN clinical practice Guidelines on Parenteral Nutrition: Present status and perspectives for future research","volume":"28","author":"Bozzetti","year":"2009","journal-title":"Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pelzer, U., Arnold, D., Govercin, M., Stieler, J., Doerken, B., Riess, H., and Oettle, H. (2010). Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-86"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/cam4.1111","article-title":"Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition","volume":"6","author":"Cotogni","year":"2017","journal-title":"Cancer Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kruger, J., Meffert, P.J., Vogt, L.J., Gartner, S., Steveling, A., Kraft, M., Mayerle, J., Lerch, M.M., and Aghdassi, A.A. (2016). Early Parenteral Nutrition in Patients with Biliopancreatic Mass Lesions, a Prospective, Randomized Intervention Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166513"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/0899-9007(95)00078-X","article-title":"The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer","volume":"12","author":"Wigmore","year":"1996","journal-title":"Nutrition"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6690654","article-title":"The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer","volume":"81","author":"Barber","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1207\/S15327914NC3602_6","article-title":"Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer","volume":"36","author":"Wigmore","year":"2000","journal-title":"Nutr. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1207\/S15327914NC402_7","article-title":"Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia","volume":"40","author":"Barber","year":"2001","journal-title":"Nutr. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","article-title":"Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia\/cachexia: A double-blind, placebo-controlled study","volume":"21","author":"Bruera","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-017-0495-5","article-title":"Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: Marine phospholipids versus fish oil\u2014A randomized controlled double-blind trial","volume":"16","author":"Werner","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_48","first-page":"2369","article-title":"Effects of omega-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy","volume":"38","author":"Abe","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Tonouchi, H., Sasayama, A., and Ashida, K. (2018). A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice. Nutrients, 10.","DOI":"10.3390\/nu10020206"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15430\/JCP.2017.22.3.127","article-title":"Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment","volume":"22","author":"Chung","year":"2017","journal-title":"J. Cancer Prev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1743-7075-8-75","article-title":"Is there a role for carbohydrate restriction in the treatment and prevention of cancer?","volume":"8","author":"Klement","year":"2011","journal-title":"Nutr. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1743-7075-8-54","article-title":"Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial","volume":"8","author":"Schmidt","year":"2011","journal-title":"Nutr. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ari, C., Seyfried, T.N., and D\u2019Agostino, D.P. (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065522"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ward, N., Seyfried, T.N., Arnold, P., and D\u2019Agostino, D.P. (2015). Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127407"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H.U., Thiede, A., and Coy, J.F. (2008). Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-122"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.nut.2012.05.001","article-title":"Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients","volume":"28","author":"Fine","year":"2012","journal-title":"Nutrition"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J. Neurooncol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Klement, R.J., and Sweeney, R.A. (2016). Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res. Notes, 9.","DOI":"10.1186\/s13104-016-1959-9"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: A pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Rieger","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00508-005-0455-3","article-title":"Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: A randomized controlled study","volume":"117","author":"Breitkreutz","year":"2005","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00520-007-0388-7","article-title":"Nutritional support in multimodal therapy for cancer cachexia","volume":"16","author":"Bosaeus","year":"2008","journal-title":"Support. Care Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/cs0960083","article-title":"Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer","volume":"96","author":"Barber","year":"1999","journal-title":"Clin. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","article-title":"Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: Systematic review","volume":"332","author":"Hooper","year":"2006","journal-title":"BMJ"},{"key":"ref_65","first-page":"6089","article-title":"Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover","volume":"51","author":"Beck","year":"1991","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/cs0940303","article-title":"Dietary fish oil suppresses human colon tumour growth in athymic mice","volume":"94","author":"Calder","year":"1998","journal-title":"Clin. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"N-3 fatty acids, cancer and cachexia: A systematic review of the literature","volume":"97","author":"Colomer","year":"2007","journal-title":"Br. J. Nutr."},{"key":"ref_69","first-page":"1385","article-title":"Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients","volume":"26","author":"Horrisberger","year":"2011","journal-title":"Nutr. Hosp."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3945\/jn.110.121202","article-title":"Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment","volume":"140","author":"Langius","year":"2010","journal-title":"J. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cncr.20362","article-title":"Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia","volume":"101","author":"Burns","year":"2004","journal-title":"Cancer"},{"key":"ref_72","first-page":"3942","article-title":"Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473","volume":"5","author":"Burns","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.3390\/ijms131115401","article-title":"Marine omega-3 phospholipids: Metabolism and biological activities","volume":"13","author":"Burri","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1476-511X-12-178","article-title":"Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil","volume":"12","author":"Ramprasath","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11745-010-3490-4","article-title":"Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers","volume":"46","author":"Ulven","year":"2011","journal-title":"Lipids"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00520-009-0640-4","article-title":"Marine phospholipids\u2014A promising new dietary approach to tumor-associated weight loss","volume":"18","author":"Taylor","year":"2010","journal-title":"Support. Care Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/nu5041301","article-title":"Alternative sources of omega-3 fats: Can we find a sustainable substitute for fish?","volume":"5","author":"Bishop","year":"2013","journal-title":"Nutrients"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"E923","DOI":"10.1152\/ajpendo.00314.2007","article-title":"Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli","volume":"293","author":"Eley","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1152\/ajpendo.90530.2008","article-title":"Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate","volume":"295","author":"Eley","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"E1417","DOI":"10.1152\/ajpendo.90567.2008","article-title":"Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate","volume":"295","author":"Eley","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1158\/0008-5472.CAN-04-1760","article-title":"Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate","volume":"64","author":"Smith","year":"2004","journal-title":"Cancer Res."},{"key":"ref_82","first-page":"713","article-title":"beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia","volume":"38","author":"Aversa","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/0008-5472.277.65.1","article-title":"Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss","volume":"65","author":"Smith","year":"2005","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nutres.2008.04.006","article-title":"Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression","volume":"28","author":"Nunes","year":"2008","journal-title":"Nutr. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clnu.2006.05.007","article-title":"Beta-hydoxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner","volume":"26","author":"Caperuto","year":"2007","journal-title":"Clin. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","article-title":"Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine","volume":"183","author":"May","year":"2002","journal-title":"Am. J. Surg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/014860710402800265","article-title":"Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters","volume":"28","author":"Rathmacher","year":"2004","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Support. Care Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20070651","article-title":"Effect of branched-chain amino acids on muscle atrophy in cancer cachexia","volume":"407","author":"Eley","year":"2007","journal-title":"Biochem. J."},{"key":"ref_90","first-page":"247","article-title":"Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice","volume":"26","author":"Peters","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2049-3002-2-6","article-title":"Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice","volume":"2","author":"Liu","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bjs.1800760215","article-title":"Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia","volume":"76","author":"Hunter","year":"1989","journal-title":"Br. J. Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpainsymman.2006.09.001","article-title":"Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: A phase I\/II study","volume":"32","author":"Cruciani","year":"2006","journal-title":"J. Pain Symptom Manag."},{"key":"ref_94","first-page":"319","article-title":"L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia","volume":"28","author":"Szefel","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0017-7","article-title":"l-carnitine and cancer cachexia: Clinical and experimental aspects","volume":"2","author":"Silverio","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpainsymman.2008.03.021","article-title":"L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: A double-blind, placebo-controlled study","volume":"37","author":"Cruciani","year":"2009","journal-title":"J. Pain Symptom Manag."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1196\/annals.1320.016","article-title":"L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: A preliminary analysis","volume":"1033","author":"Cruciani","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nut.2005.06.003","article-title":"Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy","volume":"22","author":"Gramignano","year":"2006","journal-title":"Nutrition"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)\u2014A randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr. J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2011.40.2180","article-title":"L-carnitine supplementation for the management of fatigue in patients with cancer: An eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial","volume":"30","author":"Cruciani","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1440-1746.2010.06600.x","article-title":"Pancreatic exocrine insufficiency: Diagnosis and treatment","volume":"26","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MPA.0000000000000767","article-title":"The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study","volume":"46","author":"Saito","year":"2017","journal-title":"Pancreas"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/7\/3\/89\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:03:53Z","timestamp":1760187833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/7\/3\/89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":103,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["healthcare7030089"],"URL":"https:\/\/doi.org\/10.3390\/healthcare7030089","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]}}}